2013-2014 2014-2015 2015-2016 2016-2017 2017-2018
Browse
by subject...
    Schedule
view...
 

Branimir I Sikic (Professor)

Branimir I Sikic (650) 725-6427
brandy
I'm-not-a-bot
@stanford
Personal bio
Branimir I. (Brandy) Sikic, M. D., is Professor of Medicine in the Division of Oncology at Stanford University School of Medicine. He joined the Stanford faculty since 1979. He serves as Co-Director of the Stanford Center for Clinical and Translation Research, Director of the Clinical and Translational Research Unit, and Associate Director of the Cancer Center. He received his undergraduate education (B. S. in Biology and Fine Arts) at Georgetown University, and an M. D. from the University of Chicago. He returned to Georgetown for his residency in internal medicine, and received a research fellowship in cancer pharmacology at the National Cancer Institute. He has authored more than 225 publications, edited two books, and holds two patents on mechanisms of resistance to anticancer drugs. He has served on several advisory committees of the National Institutes of Health, including as chairman of the Experimental Therapeutics I Study Section. In 2005-6 he chaired the Scientific Program Committee for the American Society of Clinical Oncology (ASCO), and in 2008-9 was co-chair of the Program Committee of the American Association for Cancer Research (AACR). Dr. Sikic is a leader in the pharmacology of anticancer drugs and the development of new cancer therapies. His research spans the spectrum from molecular and genetic approaches in cancer cells to clinical trials in cancer patients. Dr. Sikic's laboratory seeks to understand mechanisms of drug resistance in cancer cells and to develop more effective therapies. He has made major scientific and clinical contributions to understanding the problem of multidrug resistance in cancer cells. Current research ranges from molecular and genetic studies of drug resistance in cellular models to Phase I and II clinical trials of new anticancer drugs, including multikinase inhibitors, pro-apoptotic drugs, and novel combinations of targeted drugs with standard chemotherapies.

Currently teaching
BIO 300X: Out-of-Department Graduate Research (Autumn)
CBIO 299: Directed Reading in Cancer Biology (Autumn, Summer)
CBIO 399: Graduate Research (Autumn, Summer)
MED 199: Undergraduate Research (Autumn, Winter, Spring, Summer)
MED 280: Early Clinical Experience in Medicine (Autumn, Winter, Spring, Summer)
MED 299: Directed Reading in Medicine (Autumn, Winter, Spring, Summer)
MED 370: Medical Scholars Research (Autumn, Winter, Spring, Summer)
MED 399: Graduate Research (Autumn, Winter, Spring, Summer)
© Stanford University | Terms of Use | Copyright Complaints